As most of you know, I am a chartist in the market. I have been doing this for 47 years and in the 80's, I did it for Merrill Lynch and Pru-Bache. Since 2007, I have has a subscription service where I evaluate charts and give mentions to my subscribers for a $30 a month fee. I have had 12 years (of the 15 years I have offered the service) where profits were made at the end of the year.
Having said that, I am going to offer you a "freebie" mention here. I hope you take advantage of it and make some money off of it. I am in the stock myself and will be purchasing more shares this week.
Here it is:
PLNH is a Cannabis stock that is considered as one of those with the brightest future in that industry. Here is my chart evaluation from today (October 7):
PLNH generated a red weekly close and closed on the low of the week, suggesting further downside below last week’s low at .78 will be seen this week. Nonetheless, the 200-day MA is currently at .74 and that was the line that got broken to the upside 6 weeks ago, which is a line that had not been broken to the upside for 24 months. As such, a retest of that line is a normal and healthy event. On an intraweek basis, there is support at .70. With the positive fundamental changes that have occurred recently (such as the stock entering the Florida market 6 weeks ago), this is now a stock ready to be added to, using a .66 stop loss and having a short-to-midterm objective at 1.88 (based on the chart). As such, purchasing the stock near .74 and using a stop loss at .66 and having a 1.88 objective offers a 14-1 risk/reward ratio.
Oh and by the way, when the announcement of the company entering the Florida market was made, the stock rose 266% in value (from .45 to 1.20. In addition, the all-time low prior to this recent low, was at .50, a low made the 2nd week it started trading back in August 2018. The all-time high for the stock is at 8.67, seen in February 2021. As such, the stock does have tangible potential.
The fundamental analysts have a 52-week price target of $2.20 and a 5-year price target of $10.